Small non-profit's unconventional approach offers new hope with autism suramin trial

(N of One: Autism Research Foundation) Results from a new clinical trial at UCSD School of Medicine using an old drug, suramin, in boys with autism may represent one of the most dramatic advances in autism yet. The findings offer both a new view of what autism is and the possibility of the first-ever treatment for its core symptoms. The trial was supported by N of One: Autism Research Foundation, a small non-profit that has previously demonstrated success funding unorthodox autism research.